🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in China / NCT07446829
Starting soon Not applicable

Effect of Different Needle Insertion Positions on the Clinical Outcomes of YAMANE Technique

NCT07446829 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2026-02-28
Last updated
2026-03-04

Condition(s) studied

Congenital Ectopia Lentis

Investigational drug(s) / intervention(s)

YAMANE technique(Suture Needle Insertion at 2.5 mm Posterior to the Limbus)

YAMANE technique(Suture Needle Insertion at 2.5 mm Posterior to the Limbus): Participants in the intervention group should complete a comprehensive ophthalmic examination at baseline, undergo needle insertion 2.5mm post-limbal during surgery, and receive routine follow-up at 1 week, 1 month, and 3 months postoperatively.

Study summary

This is a single-blind, single-center, parallel-group randomized controlled trial with the following objectives: First, researchers aim to compare the clinical efficacy of 2mm and 2.5mm post-limbal needle insertion in YAMANE technique for patients with congenital ectopia lentis. Second, the goal is to investigate the mean absolute refractive prediction error, IOL tilt and decentration, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and corneal endothelial cell count at 3 months postoperatively. Third, it intends to explore the incidence of postoperative complications of the two needle insertion positions in this specific surgical method. Finally, this study aims to provide evidence for ophthalmic clinical practice, explore the optimal needle insertion point, and offer more precise and safe surgical plans for patients requiring sutureless transscleral IOL fixation.

Eligibility

Sex
ALL
Min age
4 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients aged 4-18 years (regardless of gender) who meet the indications for YAMANE technique. 2. Patients who can complete a follow-up period of at least 3 months after surgery. 3. Patients or their legal guardians who provide informed consent to participate in this study. Exclusion Criteria: 1. Patients with concurent secondary qlaucoma, retinal detachment, strabismus, or other relevant ocular complications (excluding refractive errors). 2. Patients participating in other trials that may affect the results of this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinical Research Center for Ocular Diseases, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science Guangdong Province

More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07446829 on ClinicalTrials.gov ↗ ← All trials in China